Cyclacel Pharmaceuticals Inc

NASDAQ:CYCC   9:35:00 AM EDT
3.59
+0.02 (+0.56%)
Earnings Announcements

Cyclacel Pharma Reports Q3 2021 Financial Results

Published: 11/10/2021 22:45 GMT
Cyclacel Pharmaceuticals Inc (CYCC) - Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update.
Cyclacel Pharmaceuticals Inc - Cash Runway to Early 2023.
Cyclacel Pharmaceuticals Inc Qtrly Loss per Share 47 Cents.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.65

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.64

More details on our Analysts Page.